Cancer Drug for SCI?

Johnston, S. Laurance
January 2012
PN;Jan2012, Vol. 66 Issue 1, p35
Trade Publication
The article focuses on the benefits of Taxol, a cancer drug for spinal-cord injury (SCI). It says that Taxol was isolated from the Pacific Yew tree. It states that Taxol slows tumor growth, as well as stabilizes the key structural components within the cell known as microtubules. It adds that Taxol reduces injury-site scarring after SCI.


Related Articles

  • Dual-Purpose Drug.  // PN;May2015, Vol. 69 Issue 5, p50 

    The article focuses on a study by the German Center for Neurodegenerative Diseases (DZNE) on the role of small doses of the cancer drug, epothilone, in the stimulation of the growth and regeneration of nerve cells without the side effects of cancer therapies.

  • Effect of ethanolic extract of pod Prosopis farcta plant on neuronal density of anterior horn following sciatic nerve compression in Rats. Tehranipour, M.; Mollashahi, M.; Javadmoosavi, B. Z. // Journal of Gorgan University of Medical Sciences;Winter2012, Vol. 14 Issue 4, p39 

    Background and Objective: After axotomy or the compersion the nerve, the death of spinal cord nerves cell body occur. Compersion is one of the factors causing the degeneration of the spinal cord cell body. This degeneration is due to the reversed factors of the damaged area that have reached to...

  • SCI Detour?  // PN;Nov2013, Vol. 67 Issue 11, p40 

    The article discusses a study published in the July 23, 2013 issue of "PLOS ONE" which reports the discovery of the protein P45 that may lead to a possible molecular mechanism that reroutes nerve signals to promote the healing of spinal cord injury (SCI) and lead to functional recovery.

  • Spatial and temporal correlation in progressive degeneration of neurons and astrocytes in contusion-induced spinal cord injury. Kyoung-Jin Min; Hey-Kyeong Jeong; Beomsue Kim; Dong Hoon Hwang; Hae Young Shin; An Tran Nguyen; Jong-hyeon Kim; Ilo Jou; Byung G. Kim; Eun-hye Joe // Journal of Neuroinflammation;2012, Vol. 9 Issue 1, p100 

    Background: Traumatic spinal cord injury (SCI) causes acute neuronal death followed by delayed secondary neuronal damage. However, little is known about how microenvironment regulating cells such as microglia, astrocytes, and blood inflammatory cells behave in early SCI states and how they...

  • Induction of Parkinson disease-related proteins in motor neurons after transient spinal cord ischemia in rabbits. Sakurai, Masahiro; Kawamura, Takae; Nishimura, Hidekazu; Suzuki, Hiroyoshi; Tezuka, Fumiaki; Abe, Koji // Journal of Cerebral Blood Flow & Metabolism;Apr2009, Vol. 29 Issue 4, p752 

    The mechanism of spinal cord injury has been thought to be related to the vulnerability of spinal motor neuron cells against ischemia. However, the mechanisms of such vulnerability are not fully understood. We investigated a possible mechanism of neuronal death by immunohistochemical analysis...

  • Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms. Sakai, Kiyoshi; Yamamoto, Akihito; Matsubara, Kohki; Nakamura, Shoko; Naruse, Mami; Yamagata, Mari; Sakamoto, Kazuma; Tauchi, Ryoji; Wakao, Norimitsu; Imagama, Shiro; Hibi, Hideharu; Kadomatsu, Kenji; Ishiguro, Naoki; Ueda, Minoru // Journal of Clinical Investigation;Jan2012, Vol. 122 Issue 1, p80 

    Spinal cord injury (SCI) often leads to persistent functional deficits due to loss of neurons and glia and to limited axonal regeneration after injury. Here we report that transplantation of human dental pulp stem cells into the completely transected adult rat spinal cord resulted in marked...

  • A Semi-Supervised Approach for Refining Transcriptional Signatures of Drug Response and Repositioning Predictions. Iorio, Francesco; Shrestha, Roshan L.; Levin, Nicolas; Boilot, Viviane; Garnett, Mathew J.; Saez-Rodriguez, Julio; Draviam, Viji M. // PLoS ONE;10/9/2015, Vol. 10 Issue 10, p1 

    We present a novel strategy to identify drug-repositioning opportunities. The starting point of our method is the generation of a signature summarising the consensual transcriptional response of multiple human cell lines to a compound of interest (namely the seed compound). This signature can be...

  • The changes in human spinal sympathetic preganglionic neurons after spinal cord injury. Krassioukov, A V; Bunge, R P; Pucket, W R; Bygrave, M A // Spinal Cord;Jan1999, Vol. 37 Issue 1, p6 

    We have applied conventional histochemical, immunocytochemical and morphometric techniques to study the changes within the human spinal sympathetic preganglionic neurons (SPNs) after spinal cord injury. SPNs are localized within the intermediolateral nucleus (IML) of the lateral horn at the...

  • Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer†. Gonzalez-Angulo, A. M.; Akcakanat, A.; Liu, S.; Green, M. C.; Murray, J. L.; Chen, H.; Palla, S. L.; Koenig, K. B.; Brewster, A. M.; Valero, V.; Ibrahim, N. K.; Moulder-Thompson, S.; Litton, J. K.; Tarco, E.; Moore, J.; Flores, P.; Crawford, D.; Dryden, M. J.; Symmans, W. F.; Sahin, A. // Annals of Oncology;Jun2014, Vol. 25 Issue 6, p1122 

    Phase II randomized study to determine pharmacodynamics (PD) changes and response of adding everolimus to standard neoadjuvant chemotherapy in triple-negative breast cancer (TNBC).Background Everolimus synergistically enhances taxane-induced cytotoxicity in breast cancer cells in vitro and in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics